1. Home
  2. BCYC vs MXL Comparison

BCYC vs MXL Comparison

Compare BCYC & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • MXL
  • Stock Information
  • Founded
  • BCYC 2009
  • MXL 2003
  • Country
  • BCYC United Kingdom
  • MXL United States
  • Employees
  • BCYC N/A
  • MXL N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • MXL Semiconductors
  • Sector
  • BCYC Health Care
  • MXL Technology
  • Exchange
  • BCYC Nasdaq
  • MXL Nasdaq
  • Market Cap
  • BCYC 1.9B
  • MXL 1.2B
  • IPO Year
  • BCYC 2019
  • MXL 2010
  • Fundamental
  • Price
  • BCYC $26.74
  • MXL $14.20
  • Analyst Decision
  • BCYC Buy
  • MXL Buy
  • Analyst Count
  • BCYC 9
  • MXL 9
  • Target Price
  • BCYC $42.00
  • MXL $23.25
  • AVG Volume (30 Days)
  • BCYC 461.6K
  • MXL 1.1M
  • Earning Date
  • BCYC 10-31-2024
  • MXL 10-23-2024
  • Dividend Yield
  • BCYC N/A
  • MXL N/A
  • EPS Growth
  • BCYC N/A
  • MXL N/A
  • EPS
  • BCYC N/A
  • MXL N/A
  • Revenue
  • BCYC $39,574,000.00
  • MXL $448,142,000.00
  • Revenue This Year
  • BCYC $58.69
  • MXL N/A
  • Revenue Next Year
  • BCYC N/A
  • MXL $24.96
  • P/E Ratio
  • BCYC N/A
  • MXL N/A
  • Revenue Growth
  • BCYC 75.74
  • MXL N/A
  • 52 Week Low
  • BCYC $12.54
  • MXL $11.08
  • 52 Week High
  • BCYC $28.67
  • MXL $26.59
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 63.17
  • MXL 52.06
  • Support Level
  • BCYC $22.82
  • MXL $13.86
  • Resistance Level
  • BCYC $28.67
  • MXL $14.99
  • Average True Range (ATR)
  • BCYC 1.35
  • MXL 0.79
  • MACD
  • BCYC 0.39
  • MXL 0.04
  • Stochastic Oscillator
  • BCYC 72.11
  • MXL 65.02

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. MaxLinear's product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices. Customers for MaxLinear include original equipment manufacturers, module makers, and original design manufacturers.

Share on Social Networks: